Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cisplatin/flavopiridol/paclitaxel

Known as: CDDP/FLAVO/TAX 
 
National Institutes of Health

Related topics

Related topics

4 relations
Alvocidib HydrochlorideCisplatinFlavopiridolPaclitaxel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Synthesis and Cytotoxic Activity of New Flavopiridol Analogs
Structural analogs of flavopiridol {2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]4-chromenone… Expand
2013
2013
Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells
BackgroundDormant cells are characterised by low RNA synthesis. In contrast, cancer cells can be addicted to high RNA synthesis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
PurposeImatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common. Flavopiridol, a cyclin-dependent… Expand
  • table 1
  • table 2
  • table 3
  • figure 3
2010
2010
A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer
Background:Flavopiridol (HMR 1275) is a synthetic flavone with antineoplastic properties through inhibition of cyclin-dependent… Expand
2007
2007
The Phases of Non-Compact QED(3)
Non-compact three-dimensional QED is studied by computer simulations to understand its chiral symmetry breaking features for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
A pr 2 00 8 The Phases of Non-Compact QED 3
Non-compact three-dimensional QED is studied by computer s imulations to understand its chiral symmetry breaking features for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2003
2003
Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.
BACKGROUND Flavopiridol is a flavonoid with antiproliferative effects mediated, in part, by inhibition of cyclin-dependent… Expand
  • figure 1
  • figure 2
  • figure 3
2002
2002
Current Clinical Trials of Flavopiridol
Flavopiridol [2-(2-chlorophenyl 5 ,7-dihydroxy-8-[cis-(3-hydroxy-1-methyl-4-piperidinyl)-4H-1-benzopyran-4-one, hydrochloride] is… Expand
Highly Cited
2000
Highly Cited
2000
Flavopiridol binds to duplex DNA.
Flavopiridol, the first potent cyclin-dependent kinase inhibitor to enter clinical trials, was recently found to be cytotoxic to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1999
Highly Cited
1999
Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.
This study investigates the roles of both ionized and un-ionized species of flavopiridol in solubilization by complexation… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE